Main > DERMATOLOGY > Herpes Virus Infection > Vaccine

Product USA. Ar

PATENT ASSIGNEE'S COUNTRY USA
UPDATE 09.00
PATENT ASSIGNEE Arch Development
PATENT CLAIMS Recombinant HSV genome having modified gamma134.5
(I) genes incapable of expressing an active ICP34.5 gene prodt., wherein the modification is selected from the group consisting of insertions, substitutions & deletions wherein the deletions have at least one terminus within the (I) genes
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back